miR-503, miR-1202, and miR-1275 |
Prognostic value |
Ozata et al. (178178. Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer. 2011;18(6):643-55, http://dx.doi.org/10.1530/ERC-11-0082. http://dx.doi.org/10.1530/ERC-11-0082...
) |
miR-483, miR-195, and miR-497 |
Diagnostic value |
Ozata et al. (178178. Özata DM, Caramuta S, Velázquez-Fernández D, Akçakaya P, Xie H, Höög A, et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr Relat Cancer. 2011;18(6):643-55, http://dx.doi.org/10.1530/ERC-11-0082. http://dx.doi.org/10.1530/ERC-11-0082...
) |
miR-483-5p |
Diagnostic value |
Patterson et al. (179179. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer. 2011;117(8):1630-9, http://dx.doi.org/10.1002/cncr.25724. http://dx.doi.org/10.1002/cncr.25724...
) |
|
|
Patel et al. (175175. Patel D, Boufraqech M, Jain M, Zhang L, He M, Gesuwan K, et al. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery. 2013;154(6):1224-8, http://dx.doi.org/10.1016/j.surg.2013.06.022. http://dx.doi.org/10.1016/j.surg.2013.06...
) |
miR-195 and miR-100 |
Biomarker in ACCs |
Patterson et al. (179179. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer. 2011;117(8):1630-9, http://dx.doi.org/10.1002/cncr.25724. http://dx.doi.org/10.1002/cncr.25724...
) |
miR-675 and miR-335 |
Diagnostic value |
Schmitz et al. (180180. Schmitz KJ, Helwig J, Bertram S, Sheu SY, Suttorp AC, Seggewiss J, et al. Differential expression of microRNA-675, http://dx.doi.org/microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J Clin Pathol. 2011;64(6):529-35, 10.1136/jcp.2010.085621. http://dx.doi.org/microRNA-139-3p and mi...
) |
miR-195 and miR-483-5p |
Prognostic value |
Chabre et al. (174174. Chabre O, Libé R, Assie G, Barreau O, Bertherat J, Bertagna X, et al. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocr Relat Cancer. 2013;20(4):579-94.) |
|
|
Soon et al. (173173. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, et al. miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res. 2009;15(24):7684-692, http://dx.doi.org/10.1158/1078-0432.CCR-09-1587. http://dx.doi.org/10.1158/1078-0432.CCR-...
) |
MiR-34a |
Diagnostic value |
Patel et al. (175175. Patel D, Boufraqech M, Jain M, Zhang L, He M, Gesuwan K, et al. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery. 2013;154(6):1224-8, http://dx.doi.org/10.1016/j.surg.2013.06.022. http://dx.doi.org/10.1016/j.surg.2013.06...
) |
miR-503-5p, miR-483-3p, miR-450a-5p, miR210, miR-483-5p, miR-421 |
Diagnostic value |
Koperski et al. (177177. Koperski Ł, Kotlarek M, Świerniak M, Kolanowska M, Kubiak A, Górnicka B, et al. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy. Oncotarget. 2017;8(30):49191-200, http://dx.doi.org/10.18632/oncotarget.16788. http://dx.doi.org/10.18632/oncotarget.16...
) |